CRON Cronos Group Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CRON

Price (delayed)

$2.925

Market cap

$1.1B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.72

Enterprise value

$239.21M

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology ...

Highlights
The company's gross margin has surged by 80% YoY and by 63% QoQ
The company's debt has shrunk by 77% YoY and by 20% QoQ
Cronos Group's equity has decreased by 16% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://thecronosgroup.com

Key stats

What are the main financial stats of CRON
Market
Shares outstanding
375.58M
Market cap
$1.1B
Enterprise value
$239.21M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.83
Price to sales (P/S)
12.63
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.75
Earnings
Revenue
$86.86M
EBIT
-$276.29M
EBITDA
-$259.94M
Free cash flow
-$146.7M
Per share
EPS
-$0.72
Free cash flow per share
-$0.39
Book value per share
$3.53
Revenue per share
$0.23
TBVPS
$3.61
Balance sheet
Total assets
$1.37B
Total liabilities
$49.63M
Debt
$2.17M
Equity
$1.32B
Working capital
$1.02B
Liquidity
Debt to equity
0
Current ratio
26.42
Quick ratio
25.26
Net debt/EBITDA
3.31
Margins
EBITDA margin
-299.3%
Gross margin
-8.8%
Net margin
-307.9%
Operating margin
-634.9%
Efficiency
Return on assets
-18.1%
Return on equity
-19.4%
Return on invested capital
-55.2%
Return on capital employed
-20.8%
Return on sales
-318.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CRON stock price

How has the Cronos Group stock price performed over time
Intraday
-3.78%
1 week
5.22%
1 month
-4.1%
1 year
-66.38%
YTD
-25.38%
QTD
-24.81%

Financial performance

How have Cronos Group's revenue and profit performed over time
Revenue
$86.86M
Gross profit
-$7.65M
Operating income
-$551.44M
Net income
-$267.43M
Gross margin
-8.8%
Net margin
-307.9%
The company's operating income has shrunk by 151% YoY
The company's gross margin has surged by 80% YoY and by 63% QoQ
Cronos Group's revenue has surged by 71% YoY and by 17% QoQ
Cronos Group's gross profit has soared by 66% YoY and by 56% from the previous quarter

Growth

What is Cronos Group's growth rate over time

Valuation

What is Cronos Group stock price valuation
P/E
N/A
P/B
0.83
P/S
12.63
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.75
Cronos Group's EPS has increased by 33% QoQ and by 17% YoY
The price to book (P/B) is 76% lower than the 5-year quarterly average of 3.6 and 43% lower than the last 4 quarters average of 1.5
Cronos Group's equity has decreased by 16% YoY
The price to sales (P/S) is 89% lower than the 5-year quarterly average of 119.1 and 58% lower than the last 4 quarters average of 31.2
Cronos Group's revenue has surged by 71% YoY and by 17% QoQ

Efficiency

How efficient is Cronos Group business performance
Cronos Group's return on sales has increased by 50% YoY and by 42% QoQ
The company's return on invested capital rose by 37% YoY and by 37% QoQ
CRON's ROE is up by 29% QoQ but it is down by 4.9% YoY
The company's return on assets rose by 27% QoQ but it fell by 11% YoY

Dividends

What is CRON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CRON.

Financial health

How did Cronos Group financials performed over time
The total liabilities has shrunk by 84% YoY and by 22% QoQ
Cronos Group's current ratio has increased by 33% from the previous quarter
The company's debt is 100% lower than its equity
The debt to equity has plunged by 100% YoY
The company's debt has shrunk by 77% YoY and by 20% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.